Kenneth Kin Man Kwong, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebrovascular Circulation | 34 | 2022 | 2733 | 2.540 |
Why?
|
| Carbon Dioxide | 5 | 2021 | 1146 | 1.360 |
Why?
|
| Magnetic Resonance Imaging | 99 | 2024 | 36286 | 1.300 |
Why?
|
| Brain Mapping | 36 | 2013 | 6569 | 1.280 |
Why?
|
| Hypercapnia | 5 | 2020 | 261 | 1.120 |
Why?
|
| Brain | 46 | 2024 | 26951 | 1.070 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 5 | 2022 | 281 | 1.060 |
Why?
|
| Oxygen | 19 | 2020 | 4193 | 0.950 |
Why?
|
| Oxytocin | 3 | 2021 | 401 | 0.910 |
Why?
|
| Echo-Planar Imaging | 17 | 2006 | 657 | 0.860 |
Why?
|
| Probiotics | 3 | 2022 | 377 | 0.720 |
Why?
|
| Respiratory Rate | 1 | 2020 | 175 | 0.660 |
Why?
|
| Acupuncture Therapy | 6 | 2010 | 480 | 0.650 |
Why?
|
| Acupuncture | 5 | 2012 | 90 | 0.640 |
Why?
|
| Adipose Tissue, Brown | 3 | 2016 | 755 | 0.640 |
Why?
|
| Visual Cortex | 15 | 2009 | 1089 | 0.620 |
Why?
|
| Oxygen Consumption | 6 | 2021 | 1843 | 0.620 |
Why?
|
| Hepatitis B, Chronic | 2 | 2013 | 403 | 0.590 |
Why?
|
| Electric Stimulation | 5 | 2011 | 1735 | 0.560 |
Why?
|
| Limbic System | 4 | 2010 | 419 | 0.500 |
Why?
|
| Image Interpretation, Computer-Assisted | 4 | 2013 | 3340 | 0.490 |
Why?
|
| Locus Coeruleus | 4 | 2024 | 231 | 0.490 |
Why?
|
| Electroacupuncture | 4 | 2009 | 66 | 0.480 |
Why?
|
| Middle Cerebral Artery | 3 | 2020 | 276 | 0.480 |
Why?
|
| Hemodynamics | 8 | 2020 | 4173 | 0.450 |
Why?
|
| Musculoskeletal Manipulations | 1 | 2013 | 24 | 0.440 |
Why?
|
| Brain Concussion | 2 | 2021 | 1394 | 0.430 |
Why?
|
| Medicine, Chinese Traditional | 1 | 2013 | 73 | 0.420 |
Why?
|
| Perfusion Imaging | 2 | 2011 | 196 | 0.420 |
Why?
|
| Dopamine | 2 | 2011 | 1595 | 0.410 |
Why?
|
| Acupuncture Points | 7 | 2012 | 111 | 0.410 |
Why?
|
| Language | 4 | 2009 | 1533 | 0.400 |
Why?
|
| Dioxoles | 1 | 2012 | 95 | 0.390 |
Why?
|
| Body Temperature Regulation | 1 | 2013 | 286 | 0.390 |
Why?
|
| Image Enhancement | 14 | 2010 | 2881 | 0.380 |
Why?
|
| Functional Laterality | 10 | 2012 | 2253 | 0.380 |
Why?
|
| Heme Oxygenase-1 | 2 | 2013 | 364 | 0.370 |
Why?
|
| Central Nervous System Stimulants | 3 | 2008 | 1174 | 0.360 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2012 | 345 | 0.360 |
Why?
|
| Amphetamine | 2 | 2008 | 224 | 0.360 |
Why?
|
| Partial Pressure | 2 | 2020 | 245 | 0.350 |
Why?
|
| Blood Volume | 11 | 2012 | 550 | 0.350 |
Why?
|
| Fibromyalgia | 1 | 2014 | 401 | 0.340 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2011 | 151 | 0.330 |
Why?
|
| Syncope | 3 | 2017 | 428 | 0.330 |
Why?
|
| Medicine, Traditional | 1 | 2009 | 87 | 0.320 |
Why?
|
| Speech Acoustics | 1 | 2009 | 154 | 0.310 |
Why?
|
| Metacarpus | 1 | 2007 | 36 | 0.310 |
Why?
|
| Thermogenesis | 1 | 2012 | 468 | 0.290 |
Why?
|
| Luminescent Measurements | 1 | 2009 | 378 | 0.290 |
Why?
|
| Blood Flow Velocity | 10 | 2022 | 1377 | 0.290 |
Why?
|
| Arrhythmias, Cardiac | 4 | 2017 | 2255 | 0.270 |
Why?
|
| Reading | 1 | 2009 | 530 | 0.250 |
Why?
|
| Respiratory Mechanics | 1 | 2009 | 699 | 0.250 |
Why?
|
| Cerebral Cortex | 4 | 2011 | 5761 | 0.250 |
Why?
|
| Visual Pathways | 2 | 2009 | 534 | 0.250 |
Why?
|
| Brain Injuries | 2 | 2014 | 2044 | 0.250 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2012 | 2782 | 0.250 |
Why?
|
| Magnetic Resonance Spectroscopy | 11 | 1998 | 3765 | 0.240 |
Why?
|
| tau Proteins | 3 | 2024 | 2095 | 0.240 |
Why?
|
| Visual Perception | 5 | 2009 | 1374 | 0.240 |
Why?
|
| Neural Inhibition | 2 | 2009 | 589 | 0.240 |
Why?
|
| Speech Perception | 1 | 2009 | 505 | 0.240 |
Why?
|
| Evoked Potentials | 3 | 2006 | 1036 | 0.230 |
Why?
|
| Positron-Emission Tomography | 5 | 2024 | 6465 | 0.220 |
Why?
|
| Adiposity | 1 | 2013 | 1858 | 0.220 |
Why?
|
| Neuroanatomy | 1 | 2003 | 70 | 0.220 |
Why?
|
| Strabismus | 2 | 2005 | 317 | 0.220 |
Why?
|
| Image Processing, Computer-Assisted | 17 | 2012 | 8950 | 0.210 |
Why?
|
| Contrast Media | 20 | 2010 | 5305 | 0.210 |
Why?
|
| Amblyopia | 1 | 2005 | 150 | 0.210 |
Why?
|
| Models, Neurological | 2 | 2010 | 1758 | 0.210 |
Why?
|
| Imaging, Three-Dimensional | 4 | 2013 | 4046 | 0.210 |
Why?
|
| Entorhinal Cortex | 1 | 2024 | 286 | 0.210 |
Why?
|
| Somatosensory Cortex | 5 | 2009 | 511 | 0.200 |
Why?
|
| Adult | 59 | 2024 | 220007 | 0.200 |
Why?
|
| Migraine Disorders | 3 | 2016 | 1693 | 0.200 |
Why?
|
| Memory, Short-Term | 2 | 2006 | 978 | 0.200 |
Why?
|
| Respiration | 2 | 2020 | 1654 | 0.190 |
Why?
|
| Brain Injury, Chronic | 1 | 2021 | 68 | 0.190 |
Why?
|
| Information Storage and Retrieval | 1 | 2006 | 822 | 0.190 |
Why?
|
| Humans | 107 | 2024 | 760613 | 0.180 |
Why?
|
| Male | 65 | 2024 | 359718 | 0.180 |
Why?
|
| Homeostasis | 1 | 2011 | 3306 | 0.180 |
Why?
|
| Habituation, Psychophysiologic | 1 | 2001 | 147 | 0.180 |
Why?
|
| Algorithms | 5 | 2011 | 13982 | 0.180 |
Why?
|
| Cerebral Arteries | 1 | 2022 | 493 | 0.180 |
Why?
|
| Forelimb | 2 | 2011 | 115 | 0.180 |
Why?
|
| Motor Cortex | 2 | 2005 | 995 | 0.170 |
Why?
|
| Pain Threshold | 2 | 2006 | 603 | 0.170 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2012 | 8158 | 0.170 |
Why?
|
| Artifacts | 5 | 2005 | 1898 | 0.170 |
Why?
|
| Benzhydryl Compounds | 1 | 2006 | 941 | 0.170 |
Why?
|
| Sleep Deprivation | 1 | 2006 | 840 | 0.170 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2005 | 952 | 0.170 |
Why?
|
| Rest | 2 | 2024 | 914 | 0.170 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2021 | 378 | 0.170 |
Why?
|
| Liver | 5 | 2011 | 7510 | 0.170 |
Why?
|
| Gadolinium DTPA | 9 | 2010 | 823 | 0.170 |
Why?
|
| Glasgow Coma Scale | 1 | 2021 | 579 | 0.170 |
Why?
|
| Female | 61 | 2024 | 391246 | 0.170 |
Why?
|
| Smell | 1 | 2001 | 259 | 0.160 |
Why?
|
| Carpal Tunnel Syndrome | 3 | 2007 | 303 | 0.160 |
Why?
|
| Databases as Topic | 1 | 2020 | 474 | 0.160 |
Why?
|
| Post-Concussion Syndrome | 1 | 2021 | 238 | 0.160 |
Why?
|
| Radiopharmaceuticals | 4 | 2012 | 2634 | 0.150 |
Why?
|
| Visual Fields | 3 | 2004 | 1054 | 0.150 |
Why?
|
| Choroid Neoplasms | 3 | 2004 | 177 | 0.150 |
Why?
|
| Animals | 41 | 2021 | 167960 | 0.150 |
Why?
|
| Pentetic Acid | 7 | 1998 | 209 | 0.140 |
Why?
|
| Rats | 13 | 2012 | 23709 | 0.140 |
Why?
|
| Iron | 6 | 2012 | 1786 | 0.140 |
Why?
|
| Sensitivity and Specificity | 10 | 2017 | 14661 | 0.140 |
Why?
|
| Alzheimer Disease | 3 | 2024 | 8561 | 0.140 |
Why?
|
| Oxides | 5 | 2004 | 401 | 0.140 |
Why?
|
| Vasodilation | 1 | 2020 | 962 | 0.130 |
Why?
|
| Melanoma, Experimental | 3 | 2004 | 562 | 0.130 |
Why?
|
| Eye | 4 | 1992 | 710 | 0.130 |
Why?
|
| Vasomotor System | 1 | 2016 | 207 | 0.130 |
Why?
|
| Organometallic Compounds | 7 | 2003 | 662 | 0.130 |
Why?
|
| Vision, Ocular | 3 | 2009 | 454 | 0.130 |
Why?
|
| Physical Stimulation | 3 | 2009 | 518 | 0.120 |
Why?
|
| Rabbits | 13 | 2004 | 4773 | 0.120 |
Why?
|
| Prefrontal Cortex | 1 | 2005 | 2212 | 0.120 |
Why?
|
| Vasospasm, Intracranial | 1 | 2016 | 215 | 0.110 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2016 | 269 | 0.110 |
Why?
|
| Phantoms, Imaging | 6 | 2006 | 2512 | 0.110 |
Why?
|
| Middle Aged | 34 | 2024 | 220359 | 0.110 |
Why?
|
| Reproducibility of Results | 8 | 2013 | 20080 | 0.100 |
Why?
|
| Neural Pathways | 4 | 2010 | 3040 | 0.100 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2012 | 2007 | 0.100 |
Why?
|
| Cognition | 4 | 2024 | 6964 | 0.100 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2005 | 1860 | 0.100 |
Why?
|
| Photic Stimulation | 9 | 2005 | 1967 | 0.100 |
Why?
|
| Reference Values | 8 | 2006 | 4925 | 0.100 |
Why?
|
| Liver Function Tests | 1 | 2013 | 524 | 0.100 |
Why?
|
| Computational Biology | 1 | 2003 | 3505 | 0.090 |
Why?
|
| Young Adult | 11 | 2021 | 58748 | 0.090 |
Why?
|
| Basal Ganglia | 2 | 2007 | 552 | 0.090 |
Why?
|
| Spin Labels | 4 | 2010 | 336 | 0.090 |
Why?
|
| Canada | 4 | 2017 | 2126 | 0.090 |
Why?
|
| Brain Neoplasms | 9 | 2010 | 8985 | 0.090 |
Why?
|
| Cardiac Output | 1 | 2013 | 838 | 0.090 |
Why?
|
| Arteries | 2 | 2011 | 1126 | 0.090 |
Why?
|
| Body Water | 5 | 1998 | 341 | 0.090 |
Why?
|
| Time Factors | 11 | 2014 | 40139 | 0.080 |
Why?
|
| Emergency Service, Hospital | 4 | 2017 | 7818 | 0.080 |
Why?
|
| Cold Temperature | 1 | 2013 | 780 | 0.080 |
Why?
|
| Pilot Projects | 4 | 2021 | 8556 | 0.080 |
Why?
|
| Heart | 3 | 2013 | 4393 | 0.080 |
Why?
|
| Carrier State | 1 | 2013 | 525 | 0.080 |
Why?
|
| Language Tests | 1 | 2009 | 190 | 0.080 |
Why?
|
| Occipital Lobe | 2 | 2001 | 373 | 0.080 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2012 | 404 | 0.080 |
Why?
|
| Neurosciences | 1 | 2013 | 353 | 0.080 |
Why?
|
| Adipose Tissue, White | 1 | 2012 | 365 | 0.080 |
Why?
|
| Inpatients | 1 | 2020 | 2580 | 0.080 |
Why?
|
| Dominance, Cerebral | 3 | 2006 | 622 | 0.080 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2016 | 1131 | 0.080 |
Why?
|
| Linguistics | 1 | 2009 | 106 | 0.080 |
Why?
|
| Disease Progression | 2 | 2024 | 13505 | 0.080 |
Why?
|
| Parkinsonian Disorders | 1 | 2011 | 284 | 0.080 |
Why?
|
| Chronic Disease | 4 | 2021 | 9288 | 0.080 |
Why?
|
| Pain | 4 | 2007 | 5066 | 0.080 |
Why?
|
| Organ Size | 1 | 2013 | 2254 | 0.080 |
Why?
|
| Cerebrum | 1 | 2009 | 132 | 0.080 |
Why?
|
| Periodicity | 1 | 2009 | 348 | 0.070 |
Why?
|
| Luciferases | 1 | 2009 | 716 | 0.070 |
Why?
|
| Neuronal Plasticity | 2 | 2007 | 1430 | 0.070 |
Why?
|
| Monte Carlo Method | 3 | 2010 | 1257 | 0.070 |
Why?
|
| Cerebrovascular Disorders | 5 | 2016 | 1501 | 0.070 |
Why?
|
| Intensive Care Units | 1 | 2020 | 3736 | 0.070 |
Why?
|
| Biomedical Research | 2 | 2020 | 3426 | 0.070 |
Why?
|
| Hospitals | 1 | 2020 | 3928 | 0.070 |
Why?
|
| Temporal Lobe | 2 | 2024 | 1688 | 0.070 |
Why?
|
| Semantics | 2 | 2009 | 599 | 0.070 |
Why?
|
| Patient Discharge | 2 | 2017 | 3474 | 0.070 |
Why?
|
| Gadolinium | 8 | 2010 | 959 | 0.070 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 2001 | 0.070 |
Why?
|
| Trigeminal Nuclei | 1 | 2006 | 39 | 0.070 |
Why?
|
| Macaca mulatta | 2 | 2011 | 2316 | 0.070 |
Why?
|
| Hindlimb | 1 | 2008 | 510 | 0.070 |
Why?
|
| Touch | 4 | 2009 | 312 | 0.070 |
Why?
|
| Attention | 3 | 2006 | 2387 | 0.070 |
Why?
|
| Psychomotor Performance | 2 | 2007 | 1878 | 0.060 |
Why?
|
| Double-Blind Method | 3 | 2024 | 12427 | 0.060 |
Why?
|
| Prospective Studies | 5 | 2024 | 54306 | 0.060 |
Why?
|
| Anisometropia | 1 | 2005 | 17 | 0.060 |
Why?
|
| Ventricular Remodeling | 1 | 2013 | 1261 | 0.060 |
Why?
|
| Contrast Sensitivity | 2 | 2005 | 235 | 0.060 |
Why?
|
| Huntington Disease | 1 | 2012 | 1141 | 0.060 |
Why?
|
| History, 21st Century | 1 | 2011 | 1575 | 0.060 |
Why?
|
| Nerve Net | 2 | 2009 | 2261 | 0.060 |
Why?
|
| Fluorocarbons | 3 | 2004 | 488 | 0.060 |
Why?
|
| Computer Simulation | 5 | 2006 | 6218 | 0.060 |
Why?
|
| Glioma | 4 | 2010 | 3420 | 0.060 |
Why?
|
| Verbal Learning | 1 | 2006 | 462 | 0.060 |
Why?
|
| Cause of Death | 1 | 2015 | 3725 | 0.060 |
Why?
|
| Recovery of Function | 1 | 2014 | 2985 | 0.060 |
Why?
|
| Equipment Failure Analysis | 1 | 2006 | 848 | 0.060 |
Why?
|
| Brain Ischemia | 3 | 2012 | 3127 | 0.060 |
Why?
|
| Brain Stem | 1 | 2009 | 857 | 0.060 |
Why?
|
| Oxygen Isotopes | 3 | 1992 | 43 | 0.060 |
Why?
|
| Periaqueductal Gray | 1 | 2004 | 110 | 0.060 |
Why?
|
| Ferrosoferric Oxide | 5 | 2004 | 348 | 0.060 |
Why?
|
| Hyperthermia, Induced | 2 | 2004 | 417 | 0.060 |
Why?
|
| Vision, Binocular | 1 | 2005 | 225 | 0.050 |
Why?
|
| Diabetes, Gestational | 1 | 2013 | 1242 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2011 | 2773 | 0.050 |
Why?
|
| China | 1 | 2009 | 2339 | 0.050 |
Why?
|
| Water | 3 | 1997 | 1407 | 0.050 |
Why?
|
| Pulmonary Embolism | 1 | 2016 | 2543 | 0.050 |
Why?
|
| Oximetry | 2 | 2016 | 461 | 0.050 |
Why?
|
| Signal Processing, Computer-Assisted | 3 | 2005 | 1489 | 0.050 |
Why?
|
| Radiation Injuries | 1 | 2010 | 1183 | 0.050 |
Why?
|
| Saccades | 2 | 2000 | 233 | 0.050 |
Why?
|
| Problem Solving | 1 | 2004 | 440 | 0.050 |
Why?
|
| Lactobacillus plantarum | 1 | 2021 | 5 | 0.050 |
Why?
|
| Albumins | 1 | 2004 | 577 | 0.050 |
Why?
|
| Coronary Circulation | 2 | 1999 | 1577 | 0.050 |
Why?
|
| Hypothalamus | 1 | 2007 | 998 | 0.050 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2007 | 1132 | 0.050 |
Why?
|
| Stimulation, Chemical | 1 | 2001 | 306 | 0.050 |
Why?
|
| Hemoglobins | 5 | 2003 | 1521 | 0.050 |
Why?
|
| Risk Assessment | 3 | 2017 | 24102 | 0.050 |
Why?
|
| Asymptomatic Diseases | 1 | 2024 | 585 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2021 | 41337 | 0.050 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2003 | 741 | 0.050 |
Why?
|
| Arousal | 1 | 2006 | 1157 | 0.050 |
Why?
|
| Aged | 18 | 2024 | 169143 | 0.050 |
Why?
|
| Anterior Chamber | 2 | 1991 | 194 | 0.050 |
Why?
|
| Fingers | 4 | 2007 | 506 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2009 | 4122 | 0.040 |
Why?
|
| Evoked Potentials, Motor | 1 | 2003 | 461 | 0.040 |
Why?
|
| APACHE | 1 | 2020 | 267 | 0.040 |
Why?
|
| Atrophy | 1 | 2005 | 1626 | 0.040 |
Why?
|
| Severity of Illness Index | 4 | 2017 | 15840 | 0.040 |
Why?
|
| Olfactory Pathways | 1 | 2001 | 132 | 0.040 |
Why?
|
| Parietal Lobe | 1 | 2005 | 850 | 0.040 |
Why?
|
| Movement | 1 | 2007 | 1474 | 0.040 |
Why?
|
| Amyloid beta-Peptides | 2 | 2024 | 3841 | 0.040 |
Why?
|
| Wakefulness | 1 | 2006 | 1255 | 0.040 |
Why?
|
| Acupuncture Analgesia | 1 | 1999 | 63 | 0.040 |
Why?
|
| Aged, 80 and over | 6 | 2024 | 58980 | 0.040 |
Why?
|
| Carbon Monoxide | 1 | 2022 | 541 | 0.040 |
Why?
|
| Aniline Compounds | 1 | 2024 | 1068 | 0.040 |
Why?
|
| Heterocyclic Compounds | 2 | 1998 | 247 | 0.040 |
Why?
|
| Amygdala | 1 | 2007 | 1351 | 0.040 |
Why?
|
| Muscle, Skeletal | 4 | 1998 | 4924 | 0.040 |
Why?
|
| Migraine with Aura | 1 | 2001 | 203 | 0.040 |
Why?
|
| Electrocardiography | 3 | 2017 | 6415 | 0.040 |
Why?
|
| Blinking | 1 | 1999 | 133 | 0.040 |
Why?
|
| Thalamus | 2 | 2006 | 1041 | 0.040 |
Why?
|
| Evoked Potentials, Visual | 1 | 2001 | 415 | 0.040 |
Why?
|
| Pain Measurement | 3 | 2009 | 3527 | 0.040 |
Why?
|
| Radionuclide Imaging | 1 | 2022 | 1975 | 0.040 |
Why?
|
| Equipment Design | 1 | 2006 | 3520 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2013 | 3454 | 0.040 |
Why?
|
| Brain Diseases | 2 | 1999 | 1540 | 0.040 |
Why?
|
| Cerebellum | 1 | 2005 | 1495 | 0.040 |
Why?
|
| Cytokines | 1 | 2013 | 7344 | 0.040 |
Why?
|
| Spermatic Cord | 1 | 1997 | 24 | 0.040 |
Why?
|
| Sensation | 1 | 2000 | 331 | 0.040 |
Why?
|
| Presenilin-1 | 1 | 2022 | 660 | 0.040 |
Why?
|
| Hyperemia | 2 | 1996 | 221 | 0.040 |
Why?
|
| Reperfusion | 1 | 1998 | 271 | 0.040 |
Why?
|
| Learning | 1 | 2007 | 1739 | 0.040 |
Why?
|
| ROC Curve | 1 | 2005 | 3568 | 0.040 |
Why?
|
| Meglumine | 2 | 1996 | 145 | 0.040 |
Why?
|
| Spermatic Cord Torsion | 1 | 1997 | 73 | 0.040 |
Why?
|
| Hemiplegia | 1 | 1997 | 136 | 0.040 |
Why?
|
| Vitreous Body | 4 | 1992 | 399 | 0.040 |
Why?
|
| Angiography | 1 | 2022 | 1605 | 0.040 |
Why?
|
| Proton Pumps | 1 | 1996 | 29 | 0.040 |
Why?
|
| Thiazoles | 1 | 2024 | 1511 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 9530 | 0.030 |
Why?
|
| Oligodendroglioma | 1 | 1998 | 279 | 0.030 |
Why?
|
| Capillary Permeability | 2 | 1998 | 768 | 0.030 |
Why?
|
| Polylysine | 1 | 1996 | 131 | 0.030 |
Why?
|
| Aqueous Humor | 3 | 1992 | 153 | 0.030 |
Why?
|
| Regional Blood Flow | 5 | 1998 | 1490 | 0.030 |
Why?
|
| Adolescent | 7 | 2021 | 87809 | 0.030 |
Why?
|
| Motion Perception | 2 | 1997 | 372 | 0.030 |
Why?
|
| Heart Failure | 3 | 2016 | 11848 | 0.030 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 12159 | 0.030 |
Why?
|
| Skin | 1 | 2009 | 4466 | 0.030 |
Why?
|
| Mathematics | 2 | 1998 | 707 | 0.030 |
Why?
|
| Tachycardia, Sinus | 1 | 2015 | 42 | 0.030 |
Why?
|
| Perfusion | 3 | 2012 | 1376 | 0.030 |
Why?
|
| Systole | 1 | 2017 | 947 | 0.030 |
Why?
|
| Models, Structural | 2 | 1993 | 341 | 0.030 |
Why?
|
| Models, Cardiovascular | 2 | 1999 | 977 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 1999 | 951 | 0.030 |
Why?
|
| Feces | 1 | 2021 | 1455 | 0.030 |
Why?
|
| Dry Eye Syndromes | 1 | 1999 | 385 | 0.030 |
Why?
|
| Mice | 4 | 2021 | 81209 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2022 | 1370 | 0.030 |
Why?
|
| Treatment Outcome | 4 | 2021 | 64981 | 0.030 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2017 | 578 | 0.030 |
Why?
|
| Age Factors | 2 | 2015 | 18413 | 0.030 |
Why?
|
| Hospital Mortality | 2 | 2020 | 5418 | 0.030 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 1996 | 507 | 0.030 |
Why?
|
| Troponin | 1 | 2017 | 516 | 0.030 |
Why?
|
| Astrocytoma | 1 | 1998 | 775 | 0.030 |
Why?
|
| Vision Disorders | 1 | 2001 | 1084 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2022 | 2119 | 0.030 |
Why?
|
| Ophthalmic Solutions | 2 | 1991 | 304 | 0.030 |
Why?
|
| Apnea | 1 | 1995 | 195 | 0.030 |
Why?
|
| Vasoconstriction | 1 | 2016 | 593 | 0.030 |
Why?
|
| Motor Activity | 2 | 2000 | 2688 | 0.030 |
Why?
|
| Silicone Elastomers | 1 | 1993 | 78 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2010 | 9278 | 0.030 |
Why?
|
| Subtraction Technique | 1 | 1995 | 510 | 0.030 |
Why?
|
| Vitreous Hemorrhage | 1 | 1992 | 48 | 0.030 |
Why?
|
| Auditory Cortex | 1 | 1996 | 362 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 1881 | 0.030 |
Why?
|
| Models, Theoretical | 4 | 2004 | 3562 | 0.030 |
Why?
|
| Ocular Physiological Phenomena | 1 | 1992 | 67 | 0.020 |
Why?
|
| Cerebral Infarction | 2 | 1997 | 982 | 0.020 |
Why?
|
| Hippocampus | 1 | 2024 | 3738 | 0.020 |
Why?
|
| Blood Pressure | 3 | 2017 | 8525 | 0.020 |
Why?
|
| Eye Hemorrhage | 1 | 1991 | 19 | 0.020 |
Why?
|
| Markov Chains | 1 | 2015 | 968 | 0.020 |
Why?
|
| Silicone Oils | 1 | 1991 | 22 | 0.020 |
Why?
|
| Blood Gas Analysis | 1 | 2012 | 379 | 0.020 |
Why?
|
| Emergency Treatment | 1 | 2015 | 498 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 2020 | 1801 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2022 | 5961 | 0.020 |
Why?
|
| Blood Vessels | 1 | 1996 | 1112 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 1996 | 1189 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 2 | 1998 | 2640 | 0.020 |
Why?
|
| Logistic Models | 2 | 2016 | 13312 | 0.020 |
Why?
|
| Child | 3 | 2022 | 79799 | 0.020 |
Why?
|
| Observation | 1 | 2012 | 312 | 0.020 |
Why?
|
| Dogs | 2 | 1993 | 3841 | 0.020 |
Why?
|
| Electroencephalography | 2 | 2006 | 6189 | 0.020 |
Why?
|
| Myopia | 1 | 1992 | 245 | 0.020 |
Why?
|
| Pattern Recognition, Visual | 1 | 1995 | 810 | 0.020 |
Why?
|
| Stroke | 1 | 2012 | 9952 | 0.020 |
Why?
|
| Chest Pain | 1 | 2017 | 1106 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2017 | 1266 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 2622 | 0.020 |
Why?
|
| Tomography, Emission-Computed | 3 | 1997 | 1121 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 8552 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2013 | 1837 | 0.020 |
Why?
|
| Microspheres | 2 | 2004 | 787 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 20509 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2012 | 1849 | 0.020 |
Why?
|
| Cerebrospinal Fluid | 1 | 1991 | 544 | 0.020 |
Why?
|
| Afferent Pathways | 1 | 2009 | 299 | 0.020 |
Why?
|
| Touch Perception | 1 | 2009 | 106 | 0.020 |
Why?
|
| Fetal Development | 1 | 2013 | 766 | 0.020 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 1996 | 1489 | 0.020 |
Why?
|
| Phosphocreatine | 2 | 1998 | 261 | 0.020 |
Why?
|
| Reaction Time | 2 | 2004 | 2075 | 0.020 |
Why?
|
| Length of Stay | 1 | 2020 | 6476 | 0.020 |
Why?
|
| Vocabulary | 1 | 2007 | 165 | 0.020 |
Why?
|
| Injections, Intravenous | 3 | 1996 | 1385 | 0.020 |
Why?
|
| Fetal Blood | 1 | 2013 | 1343 | 0.020 |
Why?
|
| Median Nerve | 1 | 2007 | 132 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2016 | 22052 | 0.020 |
Why?
|
| Linear Models | 2 | 2009 | 5877 | 0.020 |
Why?
|
| Psychophysics | 1 | 2007 | 289 | 0.020 |
Why?
|
| Plethysmography | 2 | 1996 | 174 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 1993 | 1273 | 0.020 |
Why?
|
| Necrosis | 1 | 2010 | 1612 | 0.020 |
Why?
|
| Lens, Crystalline | 3 | 1992 | 388 | 0.020 |
Why?
|
| Pons | 1 | 2006 | 239 | 0.020 |
Why?
|
| Myocardium | 2 | 1996 | 4700 | 0.020 |
Why?
|
| Prognosis | 2 | 2016 | 29661 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 18137 | 0.010 |
Why?
|
| Blood-Brain Barrier | 1 | 1991 | 1019 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 2754 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2017 | 2809 | 0.010 |
Why?
|
| Sensory Receptor Cells | 1 | 2009 | 509 | 0.010 |
Why?
|
| Breast | 1 | 1993 | 1963 | 0.010 |
Why?
|
| Neoplasm Transplantation | 2 | 1998 | 2014 | 0.010 |
Why?
|
| Diabetic Retinopathy | 1 | 1992 | 1268 | 0.010 |
Why?
|
| Radiotherapy | 1 | 2010 | 1504 | 0.010 |
Why?
|
| Task Performance and Analysis | 1 | 2007 | 759 | 0.010 |
Why?
|
| Inflammation | 1 | 2022 | 10755 | 0.010 |
Why?
|
| Magnetoencephalography | 1 | 2006 | 634 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2015 | 10185 | 0.010 |
Why?
|
| Leg | 2 | 1998 | 1091 | 0.010 |
Why?
|
| Internationality | 1 | 2007 | 1004 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2009 | 2913 | 0.010 |
Why?
|
| Oxidation-Reduction | 2 | 1998 | 2222 | 0.010 |
Why?
|
| Sex Factors | 1 | 2015 | 10546 | 0.010 |
Why?
|
| Data Display | 1 | 2001 | 174 | 0.010 |
Why?
|
| Echocardiography | 1 | 2013 | 4981 | 0.010 |
Why?
|
| Hot Temperature | 1 | 2006 | 1435 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 2003 | 959 | 0.010 |
Why?
|
| Models, Biological | 1 | 1996 | 9468 | 0.010 |
Why?
|
| Toes | 1 | 2000 | 209 | 0.010 |
Why?
|
| Diffusion | 2 | 1992 | 813 | 0.010 |
Why?
|
| Oxyhemoglobins | 1 | 2000 | 212 | 0.010 |
Why?
|
| Darkness | 1 | 1999 | 158 | 0.010 |
Why?
|
| Computer Graphics | 1 | 2001 | 341 | 0.010 |
Why?
|
| Lasers | 1 | 2003 | 952 | 0.010 |
Why?
|
| Drug Combinations | 2 | 1996 | 2025 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1996 | 6316 | 0.010 |
Why?
|
| Heart Rate | 2 | 2003 | 4180 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2021 | 42056 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2007 | 6238 | 0.010 |
Why?
|
| Blood Volume Determination | 1 | 1997 | 41 | 0.010 |
Why?
|
| Technetium Tc 99m Pentetate | 1 | 1997 | 67 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 22020 | 0.010 |
Why?
|
| Models, Animal | 1 | 2004 | 2117 | 0.010 |
Why?
|
| Kidney | 1 | 2013 | 7064 | 0.010 |
Why?
|
| Risk Factors | 2 | 2016 | 74333 | 0.010 |
Why?
|
| Half-Life | 1 | 1998 | 652 | 0.010 |
Why?
|
| Mutation | 1 | 2022 | 29957 | 0.010 |
Why?
|
| Volition | 1 | 1997 | 62 | 0.010 |
Why?
|
| Retinal Detachment | 2 | 1992 | 427 | 0.010 |
Why?
|
| Laser Therapy | 1 | 2003 | 1089 | 0.010 |
Why?
|
| Dipyridamole | 1 | 1996 | 143 | 0.010 |
Why?
|
| Oxidative Phosphorylation | 1 | 1998 | 495 | 0.010 |
Why?
|
| Supine Position | 1 | 1996 | 205 | 0.010 |
Why?
|
| Mathematical Computing | 1 | 1996 | 143 | 0.010 |
Why?
|
| Acoustic Stimulation | 1 | 2000 | 1232 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 1996 | 825 | 0.010 |
Why?
|
| Magnetics | 1 | 1998 | 600 | 0.010 |
Why?
|
| Heart Septum | 1 | 1996 | 303 | 0.010 |
Why?
|
| Cues | 1 | 2000 | 867 | 0.010 |
Why?
|
| Hand | 1 | 2000 | 903 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2016 | 11890 | 0.010 |
Why?
|
| Cell Transplantation | 1 | 1996 | 472 | 0.010 |
Why?
|
| Species Specificity | 1 | 1999 | 2418 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 6130 | 0.010 |
Why?
|
| Fourier Analysis | 1 | 1995 | 439 | 0.010 |
Why?
|
| Haplorhini | 1 | 1995 | 529 | 0.010 |
Why?
|
| Hemianopsia | 1 | 1995 | 121 | 0.010 |
Why?
|
| Color Perception | 1 | 1995 | 212 | 0.010 |
Why?
|
| Macaca | 1 | 1995 | 409 | 0.010 |
Why?
|
| Eye Movements | 1 | 1997 | 508 | 0.010 |
Why?
|
| Exercise Tolerance | 1 | 1998 | 830 | 0.010 |
Why?
|
| Hyperopia | 1 | 1992 | 41 | 0.010 |
Why?
|
| United States | 1 | 2020 | 72448 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1994 | 1316 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 1996 | 978 | 0.010 |
Why?
|
| Light | 1 | 1998 | 1344 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1996 | 2235 | 0.010 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1996 | 1067 | 0.010 |
Why?
|
| Pregnancy | 1 | 2013 | 29746 | 0.010 |
Why?
|
| Deuterium | 1 | 1991 | 105 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1992 | 2094 | 0.010 |
Why?
|
| Acetazolamide | 1 | 1991 | 96 | 0.010 |
Why?
|
| Anisotropy | 1 | 1994 | 1278 | 0.010 |
Why?
|
| Choroid | 1 | 1992 | 349 | 0.010 |
Why?
|
| Ciliary Body | 1 | 1991 | 166 | 0.010 |
Why?
|
| Magnetite Nanoparticles | 1 | 1992 | 316 | 0.010 |
Why?
|
| Dextrans | 1 | 1992 | 574 | 0.010 |
Why?
|
| Administration, Topical | 1 | 1992 | 697 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 1996 | 2362 | 0.010 |
Why?
|
| Iris | 1 | 1991 | 231 | 0.010 |
Why?
|
| Magnetic Resonance Angiography | 1 | 1996 | 1431 | 0.010 |
Why?
|
| Biometry | 1 | 1992 | 559 | 0.010 |
Why?
|
| Swine | 1 | 1999 | 5899 | 0.000 |
Why?
|
| Affect | 1 | 1996 | 1480 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2016 | 80345 | 0.000 |
Why?
|
| Energy Metabolism | 1 | 1998 | 2869 | 0.000 |
Why?
|
| Cataract | 1 | 1992 | 827 | 0.000 |
Why?
|
| Coronary Vessels | 1 | 1996 | 3112 | 0.000 |
Why?
|
| Radiography | 1 | 1995 | 6965 | 0.000 |
Why?
|
| Kinetics | 1 | 1991 | 6377 | 0.000 |
Why?
|
| Cornea | 1 | 1991 | 1326 | 0.000 |
Why?
|
| Visual Acuity | 1 | 1992 | 2643 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1994 | 10826 | 0.000 |
Why?
|
| Models, Statistical | 1 | 1996 | 5075 | 0.000 |
Why?
|
| Exercise | 1 | 1996 | 5787 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1996 | 39262 | 0.000 |
Why?
|